34 related articles for article (PubMed ID: 34031899)
1. The first CD73-instructed supramolecular hydrogel.
Wu D; Du X; Shi J; Zhou J; Zhou N; Xu B
J Colloid Interface Sci; 2015 Jun; 447():269-72. PubMed ID: 25524006
[TBL] [Abstract][Full Text] [Related]
2. Posttranslational protein modifications as gatekeepers of cancer immunogenicity.
Marchese E; Demehri S
J Clin Invest; 2024 May; 134(10):. PubMed ID: 38747288
[TBL] [Abstract][Full Text] [Related]
3. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma.
Coy S; Wang S; Stopka SA; Lin JR; Yapp C; Ritch CC; Salhi L; Baker GJ; Rashid R; Baquer G; Regan M; Khadka P; Cole KA; Hwang J; Wen PY; Bandopadhayay P; Santi M; De Raedt T; Ligon KL; Agar NYR; Sorger PK; Touat M; Santagata S
Nat Commun; 2022 Aug; 13(1):4814. PubMed ID: 35973991
[TBL] [Abstract][Full Text] [Related]
4. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment.
Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ
Front Immunol; 2022; 13():975847. PubMed ID: 36091055
[TBL] [Abstract][Full Text] [Related]
5. Evidence that cervical cancer cells cultured as tumorspheres maintain high CD73 expression and increase their protumor characteristics through TGF-β production.
García-Rocha R; Monroy-García A; Carrera-Martínez M; Hernández-Montes J; Don-López CA; Weiss-Steider B; Monroy-Mora KA; Ponce-Chavero MLÁ; Montesinos-Montesinos JJ; Escobar-Sánchez ML; Castillo GM; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Mora-García ML
Cell Biochem Funct; 2022 Oct; 40(7):760-772. PubMed ID: 36070413
[TBL] [Abstract][Full Text] [Related]
6. The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine.
Passarelli A; Tucci M; Mannavola F; Felici C; Silvestris F
Tumour Biol; 2019 Apr; 42(4):1010428319837138. PubMed ID: 30957676
[TBL] [Abstract][Full Text] [Related]
7. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
Gao ZW; Wang HP; Lin F; Wang X; Long M; Zhang HZ; Dong K
BMC Cancer; 2017 Feb; 17(1):135. PubMed ID: 28202050
[TBL] [Abstract][Full Text] [Related]
8. CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer.
Chen Q; Pu N; Yin H; Zhang J; Zhao G; Lou W; Wu W
J Cell Mol Med; 2020 Aug; 24(15):8674-8686. PubMed ID: 32643277
[TBL] [Abstract][Full Text] [Related]
9. Activity of ecto-5'-nucleotidase (NT5E/CD73) is increased in papillary thyroid carcinoma and its expression is associated with metastatic lymph nodes.
Bertoni APS; Bracco PA; de Campos RP; Lutz BS; Assis-Brasil BM; Meyer ELS; Saffi J; Braganhol E; Furlanetto TW; Wink MR
Mol Cell Endocrinol; 2019 Jan; 479():54-60. PubMed ID: 30184475
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells.
Fortunato O; Belisario DC; Compagno M; Giovinazzo F; Bracci C; Pastorino U; Horenstein A; Malavasi F; Ferracini R; Scala S; Sozzi G; Roz L; Roato I; Bertolini G
Front Immunol; 2020; 11():02168. PubMed ID: 33123122
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1.
García-Rocha R; Monroy-García A; Hernández-Montes J; Weiss-Steider B; Gutiérrez-Serrano V; Del Carmen Fuentes-Castañeda M; Ávila-Ibarra LR; Don-López CA; Torres-Pineda DB; de Lourdes Mora-García M
Cytokine; 2019 Jun; 118():71-79. PubMed ID: 30301599
[TBL] [Abstract][Full Text] [Related]
12. A three-dimensional microenvironment alters CD73 expression in cervical cancer.
Iser IC; de Andrade Mello P; Davies S; de Souza Santos JF; Pilger DA; Buffon A; Bertoni APS; Wink MR
Cell Biochem Funct; 2021 Aug; 39(6):780-790. PubMed ID: 34031899
[TBL] [Abstract][Full Text] [Related]
13. The roles of CD73 in cancer.
Gao ZW; Dong K; Zhang HZ
Biomed Res Int; 2014; 2014():460654. PubMed ID: 25126561
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]